Literature DB >> 18695181

Anemia of chronic disease: a harmful disorder or an adaptive, beneficial response?

Ryan Zarychanski1, Donald S Houston.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18695181      PMCID： PMC2492976          DOI： 10.1503/cmaj.071131

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  45 in total

1.  THE CARDIAC OUTPUT IN PATIENTS WITH CHRONIC ANEMIA AS MEASURED BY THE TECHNIQUE OF RIGHT ATRIAL CATHETERIZATION.

Authors:  E S Brannon; A J Merrill; J V Warren; E A Stead
Journal:  J Clin Invest       Date:  1945-05       Impact factor: 14.808

2.  Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study.

Authors:  Brian Leyland-Jones; Vladimir Semiglazov; Marek Pawlicki; Tadeusz Pienkowski; Sergei Tjulandin; George Manikhas; Antoly Makhson; Anton Roth; David Dodwell; Jose Baselga; Mikhail Biakhov; Konstantinas Valuckas; Edouard Voznyi; Xiangyang Liu; Els Vercammen
Journal:  J Clin Oncol       Date:  2005-08-08       Impact factor: 44.544

3.  Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review.

Authors:  J J Caro; M Salas; A Ward; G Goss
Journal:  Cancer       Date:  2001-06-15       Impact factor: 6.860

4.  Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial.

Authors:  C Gasché; C Dejaco; T Waldhoer; W Tillinger; W Reinisch; G F Fueger; A Gangl; H Lochs
Journal:  Ann Intern Med       Date:  1997-05-15       Impact factor: 25.391

Review 5.  Prognostic evaluation of primary non-small cell lung carcinoma patients using biological fluid variables. A systematic review.

Authors:  J Watine
Journal:  Scand J Clin Lab Invest       Date:  2000-07       Impact factor: 1.713

6.  Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials.

Authors:  Ryan Zarychanski; Alexis F Turgeon; Lauralyn McIntyre; Dean A Fergusson
Journal:  CMAJ       Date:  2007-09-05       Impact factor: 8.262

7.  Efficacy and safety of epoetin alfa in critically ill patients.

Authors:  Howard L Corwin; Andrew Gettinger; Timothy C Fabian; Addison May; Ronald G Pearl; Stephen Heard; Robert An; Peter J Bowers; Paul Burton; Mark A Klausner; Michael J Corwin
Journal:  N Engl J Med       Date:  2007-09-06       Impact factor: 91.245

Review 8.  Physiologic aspects of anemia.

Authors:  Paul C Hébert; Phillipe Van der Linden; George Biro; Ling Qun Hu
Journal:  Crit Care Clin       Date:  2004-04       Impact factor: 3.598

9.  The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States.

Authors:  Howard L Corwin; Andrew Gettinger; Ronald G Pearl; Mitchell P Fink; Mitchell M Levy; Edward Abraham; Neil R MacIntyre; M Michael Shabot; Mei-Sheng Duh; Marc J Shapiro
Journal:  Crit Care Med       Date:  2004-01       Impact factor: 7.598

10.  Tolerance to acute isovolemic hemodilution. Effect of anesthetic depth.

Authors:  Philippe Van der Linden; Stefan De Hert; Nathalie Mathieu; Françoise Degroote; Denis Schmartz; Haibo Zhang; Jean-Louis Vincent
Journal:  Anesthesiology       Date:  2003-07       Impact factor: 7.892
View more
  30 in total

Review 1.  Immunostimulation in the era of the metagenome.

Authors:  Amy D Proal; Paul J Albert; Greg P Blaney; Inge A Lindseth; Chris Benediktsson; Trevor G Marshall
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

Review 2.  [Patient Blood Management : three pillar strategy to improve outcome through avoidance of allogeneic blood products].

Authors:  H Gombotz; A Hofmann
Journal:  Anaesthesist       Date:  2013-07       Impact factor: 1.041

Review 3.  Management of Anemia in Patients with Inflammatory Bowel Disease (IBD).

Authors:  Dhruvan Patel; Chinmay Trivedi; Nabeel Khan
Journal:  Curr Treat Options Gastroenterol       Date:  2018-03

4.  Anemia in elderly people: Risk marker or risk factor?

Authors:  Ora Paltiel; A Mark Clarfield
Journal:  CMAJ       Date:  2009-07-27       Impact factor: 8.262

5.  Physiological and pathological population dynamics of circulating human red blood cells.

Authors:  John M Higgins; L Mahadevan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

Review 6.  Harms of off-label erythropoiesis-stimulating agents for critically ill people.

Authors:  Bita Mesgarpour; Benedikt H Heidinger; Dominik Roth; Susanne Schmitz; Cathal D Walsh; Harald Herkner
Journal:  Cochrane Database Syst Rev       Date:  2017-08-25

7.  Plasma hepcidin levels and anemia in old age. The Leiden 85-Plus Study.

Authors:  Wendy P J den Elzen; Anton J M de Craen; Erwin T Wiegerinck; Rudi G J Westendorp; Dorine W Swinkels; Jacobijn Gussekloo
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

Review 8.  HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond.

Authors:  Patrick H Maxwell; Kai-Uwe Eckardt
Journal:  Nat Rev Nephrol       Date:  2015-12-14       Impact factor: 28.314

9.  Effect of anemia and comorbidity on functional status and mortality in old age: results from the Leiden 85-plus Study.

Authors:  Wendy P J den Elzen; Jorien M Willems; Rudi G J Westendorp; Anton J M de Craen; Willem J J Assendelft; Jacobijn Gussekloo
Journal:  CMAJ       Date:  2009-07-27       Impact factor: 8.262

10.  Ferritin prevents calcification and osteoblastic differentiation of vascular smooth muscle cells.

Authors:  Abolfazl Zarjou; Viktória Jeney; Paolo Arosio; Maura Poli; Péter Antal-Szalmás; Anupam Agarwal; György Balla; József Balla
Journal:  J Am Soc Nephrol       Date:  2009-05-07       Impact factor: 10.121
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.